Suppr超能文献

血清血红蛋白水平是否为 IgA 肾病的独立预后因素?:观察性队列研究的系统评价和荟萃分析。

Is serum hemoglobin level an independent prognostic factor for IgA nephropathy?: a systematic review and meta-analysis of observational cohort studies.

机构信息

Department of Nephrology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.

出版信息

Ren Fail. 2023 Dec;45(1):2171885. doi: 10.1080/0886022X.2023.2171885.

Abstract

BACKGROUND

Decreased serum hemoglobin (Hb) level is associated with Immunoglobulin A nephropathy (IgAN) progression. However, whether serum Hb level is an independent prognostic factor of IgAN remains controversial. Herein, we aimed to investigate the prognostic value of serum Hb level in IgAN.

METHODS

The Cochrane Library, Embase, PubMed and Open Grey databases were systematically searched and reviewed. Kidney disease progression of IgAN was defined as a doubling of serum creatinine (SCr), a 30% reduction in estimated glomerular filtration rate (eGFR), end-stage renal disease (ESRD), or death. We evaluated the hazard ratio (HR) between serum Hb level and the incidence of kidney disease progression in IgAN before and after adjusting for relevant covariates.

RESULTS

We included nine studies with 10006 patients in the meta-analysis. As a continuous variable, we found that serum Hb was an independent prognostic factor of IgAN [unadjusted HR = 0.89, 95% confidence interval (CI) = 0.84-0.95, = 98%; adjusted HR = 0.85, 95% CI = 0.79-0.91, = 0%]. The sensitivity analysis confirmed the stability of these results. Consistently, as a dichotomous variable defined as the below/above cutoff for anemia, we observed a positive correlation between serum Hb and kidney disease progression in IgAN (unadjusted HR = 2.12, 95% CI = 1.44-3.12, = 79%; adjusted HR = 1.65, 95% CI = 1.20-2.27, = 0%).

CONCLUSION

Serum Hb level was independently correlated with the incidence of kidney disease progression in IgAN.

摘要

背景

血清血红蛋白(Hb)水平降低与 IgA 肾病(IgAN)进展有关。然而,血清 Hb 水平是否为 IgAN 的独立预后因素仍存在争议。本研究旨在探讨血清 Hb 水平在 IgAN 中的预后价值。

方法

系统检索 Cochrane 图书馆、Embase、PubMed 和 Open Grey 数据库并进行综述。IgAN 的肾脏疾病进展定义为血清肌酐(SCr)翻倍、估算肾小球滤过率(eGFR)降低 30%、终末期肾病(ESRD)或死亡。我们评估了血清 Hb 水平与 IgAN 肾脏疾病进展发生率之间的风险比(HR),并在调整了相关协变量后进行了分析。

结果

我们纳入了 9 项研究,共纳入 10006 例患者进行荟萃分析。作为连续变量,我们发现血清 Hb 是 IgAN 的独立预后因素[未调整 HR = 0.89,95%置信区间(CI)= 0.84-0.95, = 98%;调整 HR = 0.85,95% CI = 0.79-0.91, = 0%]。敏感性分析证实了这些结果的稳定性。同样,作为以贫血截断值定义的二分变量,我们观察到血清 Hb 与 IgAN 肾脏疾病进展之间呈正相关(未调整 HR = 2.12,95% CI = 1.44-3.12, = 79%;调整 HR = 1.65,95% CI = 1.20-2.27, = 0%)。

结论

血清 Hb 水平与 IgAN 肾脏疾病进展的发生率独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e0/9888460/713b4cfd7bbb/IRNF_A_2171885_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验